Advanced Medicine

Health outlets are highlighting an mRNA vaccine being developed for melanoma, the deadliest form of skin cancer. The approach uses the same mRNA technology proven in COVID-19 vaccines, training the immune system to recognize and attack tumor cells. WVU Medicine shared the update, and the item is drawing attention as trials of personalized cancer vaccines continue to advance globally.

California Senator John Laird has secured a new law expanding access to long-acting HIV prevention medicine, such as injectable pre-exposure prophylaxis. The legislation is intended to make the prevention option more widely available to people at risk of HIV, reducing reliance on daily pills. It is being highlighted by Laird's office as a public health advance in the state's ongoing response to the HIV epidemic.

A new blood test can differentiate between bacterial and viral infections in newborns, according to a report by Inside Precision Medicine. The development could help doctors decide when antibiotics are truly needed in infants, where diagnosing infection has long been difficult and often leads to precautionary antibiotic use. The finding is drawing attention in medical and precision diagnostics circles.

Scientists are increasingly using artificial intelligence to speed up the discovery of new materials and to improve medical diagnosis. The approach is reshaping research in physics, chemistry and medicine, with AI tools helping researchers identify promising compounds and detect diseases earlier and more accurately than traditional methods.

Engineers have developed tiny flying robots that contain no motors or propellers, instead using sound waves to generate lift and steer through the air. The advance points toward new possibilities for miniature aerial machines in medicine, sensing and environmental monitoring, and researchers say the approach removes the hard limits that batteries and moving parts impose at microscale sizes.

Penn Medicine and Belgian proton therapy company IBA have announced a joint venture to support the development of proton therapy and radiation oncology programs worldwide. The partnership aims to help hospitals and clinics internationally establish and expand advanced cancer treatment services, combining Penn Medicine's clinical expertise with IBA's technology. The announcement has been picked up by financial and international news outlets.

Researchers report that a 'proliferative pause' — a dormant phase cancer cells enter before spreading — may offer a critical window to intervene and stop brain metastasis before it takes hold. The findings, covered by Inside Precision Medicine, suggest targeting cells during this quiet period could prevent secondary brain tumours, a major cause of death in patients with advanced cancers such as breast cancer and melanoma.

Penn Medicine and Belgian medical technology company IBA have formed a joint venture aimed at advancing proton therapy and radiation oncology. The partnership will combine Penn Medicine's clinical expertise with IBA's technology to develop and expand proton therapy treatments for cancer patients.

IBA and Penn Medicine have announced a joint venture called the Noventra Oncology Alliance, combining the particle therapy technology company's expertise with the academic medical center's clinical and research capabilities. The partnership is aimed at advancing cancer treatment, though further details about its scope, funding and first projects have not yet been made widely available.

The Howard and Georgeanna Jones Foundation for Reproductive Medicine has announced that Georgeanna Seegar Jones, MD, is being inducted into the National Women's Hall of Fame. Jones was a leading figure in reproductive medicine and, together with her husband Howard Jones, helped advance fertility treatment in the United States. The foundation announced the honor in a press release.

Navy Medicine Readiness and Training Command Cherry Point has announced that Sailors at the North Carolina installation have been frocked to Hospital Corpsman, meaning they now wear the rank of their next position while awaiting official promotion. The Naval Health Clinic Cherry Point published the announcement, honoring the corpsmen's advancement and readiness role supporting Marine Corps aviation units and medical operations at the base.

Global medicines regulators have issued a joint call to advance alternatives to animal testing across the entire lifecycle of medicine development, from early research through safety evaluation and post-market monitoring. The European Medicines Agency is among the bodies backing the initiative, which aims to accelerate adoption of non-animal methods while maintaining safety standards for new drugs.

The Jordan Smelski Foundation has made a significant gift to Purdue University's College of Veterinary Medicine to support research into Naegleria fowleri, the deadly brain-eating amoeba. The funding will advance scientific work on the infection, which is rare but almost always fatal. The foundation is named after Jordan Smelski, who died from the amoeba infection.

The Human RNome Project Consortium is working toward publishing the first-ever complete sequence of the body's RNA, complementing the genome by mapping the full set of RNA molecules. The project would give researchers a new layer of understanding of how genes are expressed and could advance research into disease and therapeutics, drawing attention from the scientific community.

Researchers report a breakthrough in controlling supramolecular materials, achieving a new level of precision in how their molecular building blocks are assembled. The advance, covered by science news outlets, could make it easier to design materials with highly specific structures and functions for applications in medicine, electronics, and soft materials.

Five rural hospitals in West Virginia are set to receive artificial intelligence technology for health care delivery. The announcement highlights efforts to bring advanced digital tools to underserved rural facilities, where staffing shortages and limited resources often strain patient care. Details about which hospitals are involved, the technology provider, and funding have not been disclosed, but the move is being covered as a notable step for rural health care in the state.

The University of Arizona College of Medicine – Phoenix is highlighting Julie E. Bauman, MD, MPH, in its Women in Medicine and Science feature. Bauman, a physician-leader known for her work in cancer care and research, is presented as an example of women advancing in academic medicine and science, drawing attention to their contributions in the field.

Researchers have unveiled a paper-thin robot driven by living muscle cells that can swim its way through an underwater maze. The biohybrid device, reported by Tech Xplore, demonstrates how engineered muscle tissue can be used to propel soft microrobots through complex aquatic environments, a step with potential applications in medicine and targeted delivery.

Duke physician-scientist Jennifer Plichta is drawing attention for her work fighting breast cancer, described as a personal war on the disease. Her efforts focus on research and care aimed at improving prevention, detection and treatment outcomes for patients. The profile has sparked conversation about her role in advancing breast cancer medicine at Duke.

The Keck School of Medicine of the University of Southern California has received an $8 million grant from the National Institutes of Health to advance research on environmental health. The funding will support studies into how environmental exposures affect human health, strengthening the school's work in a field of growing public concern.

Weill Cornell Medicine has received $3 million to establish a new research center focused on how HIV affects the brain. The funding will support studies into the neurological effects of the virus, an area that remains underexplored even as antiretroviral therapy has extended the lives of people living with HIV. Researchers hope the center will advance understanding of HIV-related cognitive decline and lead to better treatments for affected patients.

Northwestern University has announced plans to launch a $30 million research center focused on unlocking the genome's hidden code. The initiative will aim to better understand parts of the genome whose functions remain poorly understood, potentially advancing research in genetics and medicine. Details beyond the announcement have not yet been released.

Tampa General Hospital has secured funding to establish a new Center for Lymphatic Education and Research. The center is intended to advance education and scientific study of the lymphatic system, an area of medicine that has historically received limited research attention. The announcement, reported by South Florida Hospital News, marks a step forward for specialized lymphatic care in the region.

The North Texas Maternal Health Accelerator has been awarded $4 million to advance its work improving maternal health outcomes in the region. The funding is associated with the Burnett School of Medicine at TCU, which announced the award. The initiative is aimed at strengthening efforts to address maternal health challenges in North Texas.

Yale School of Medicine is highlighting advances in CAR-T therapy, a treatment that engineers a patient's immune cells to fight disease. Originally developed for blood cancers, the approach is now being adapted and studied for autoimmune conditions, marking a significant expansion of its potential use in medicine.

Researchers have equipped a paper-thin robot with living muscle tissue, giving the tiny machine a dramatic boost in strength and movement. The biohybrid design suggests new possibilities for soft robotics in medicine and delicate tasks. Details of the team and institution behind the work remain sparse, but the fusion of biological muscle with ultra-thin robotic frames is drawing attention across the robotics field.

Yale Medicine reports that recent advances in treating head and neck cancer are leading to better patient outcomes. The overview highlights progress in therapies for these cancers, which affect the throat, mouth, voice box and surrounding areas. The message underscores growing optimism among clinicians about improved survival and quality of life, though the report does not detail specific new treatments or clinical trial results.